Abstract:Background The pathogenesis of Cushing's disease (CD) is still not adequately understood despite the identification of somatic driver mutations in USP8, BRAF, and USP48. In this multiomics study, we combined RNA sequencing (RNA-seq) with Sanger sequencing to depict transcriptional dysregulation under different gene mutation backgrounds. Furthermore, we evaluated the potential of achaete-scute complex homolog 1 (ASCL1), a pioneer transcription factor, as a novel therapeutic target for treatment of CD and its possible downstream pathway. Methods RNA-seq was adopted to investigate the gene expression profile of CD, and Sanger sequencing was adopted to detect gene mutations. Bioinformatics analysis was used to depict transcriptional dysregulation under different gene mutation backgrounds. The function of ASCL1 in hormone secretion, cell proliferation, and apoptosis were studied in vitro. The effectiveness of an ASCL1 inhibitor was evaluated in primary CD cells, and the clinical relevance of ASCL1 was examined in 68 patients with CD. RNA-seq in AtT-20 cells on Ascl1 knockdown combined with published chromatin immunoprecipitation sequencing data and dual luciferase assays were used to explore downstream pathways. Results ASCL1 was exclusively overexpressed in USP8-mutant and wild-type tumors. Ascl1 promoted adrenocorticotrophin hormone overproduction and tumorigenesis and directly regulated Pomc in AtT-20 cells. An ASCL1 inhibitor presented promising efficacy in both AtT-20 and primary CD cells. ASCL1 overexpression was associated with a larger tumor volume and higher adrenocorticotrophin secretion in patients with CD. Conclusion Our findings help to clarify the pathogenesis of CD and suggest that ASCL1 is a potential therapeutic target the treatment of CD. The pathogenesis of Cushing's disease (CD) is still not adequately understood despite the identification of somatic driver mutations in USP8, BRAF, and USP48. Moreover, few effective medical therapies are currently available for the treatment of CD. Here, using a multiomics approach, we first report the aberrant overexpression of the transcription factor gene ASCL1 in USP8-mutant and wild-type tumors of CD. Ascl1 promoted adrenocorticotrophin hormone overproduction and tumorigenesis and directly regulated Pomc in mouse AtT-20 cells. Notably, an ASCL1 inhibitor presented promising efficacy in both AtT-20 and primary CD cells. Importantly, ASCL1 overexpression was associated with a larger tumor volume and higher adrenocorticotrophin secretion in patients with CD. Thus, our findings improve understanding of CD pathogenesis and suggest that ASCL1 is a potential therapeutic target the treatment of CD.

Activating hotspot L205R mutation in PRKACA and adrenal Cushing’s syndrome

Activating Hotspot L205R Mutation in PRKACA and Adrenal Cushing's Syndrome.

Recurrent Gain-Of-Function Usp8 Mutations in Cushing'S Disease

Clinical Characteristics of PRKACA Mutations in Chinese Patients with Adrenal Lesions: a Single‐centre Study

Discovery of a Cushing's syndrome protein kinase A mutant that biases signaling through type I AKAPs

Transcription Factor ASCL1 Acts as a Novel Potential Therapeutic Target for the Treatment of the Cushing's Disease

Steroidogenic Acute Regulatory Protein Overexpression Correlates With Protein Kinase A Activation In Adrenocortical Adenoma

Mutational landscape of non-functiona adrenocortical adenomas

The molecular genetics of adrenal cushing

Molecular Cluster Mining of Adrenocortical Carcinoma Via Multi-Omics Data Analysis Aids Precise Clinical Therapy.

Mosaic <i>PRKACA</i> duplication causing a novel and distinct phenotype of early-onset Cushing's syndrome and acral cutaneous mucinosis

Germline PRKACA amplification-associated primary pigmented nodular adrenocortical disease: a case report and literature review

Mitotane Treatment Combined With Unilateral Adrenalectomy in a Patient With Primary Pigmented Nodular Adrenocortical Disease Caused by a Start Codon Mutation of PRKAR1A Gene

THU478 Unchecked Kinase Activation Underlies Pituitary Adenomas Causing Cushing’s Disease

Cyclic Cushing’s Syndrome Caused by Neuroendocrine Tumor: a Case Report

Aberrant DNA methylation of synaptophysin is involved in adrenal cortisol-producing adenoma.

Cushing syndrome: uncovering Carney complex due to novel PRKAR1A mutation

Concurrent mutations of germline GPR101 and somatic USP8 in a pediatric giant pituitary ACTH adenoma: a case report

A Novel Germline ARMC5 Mutation in a Patient with Bilateral Macronodular Adrenal Hyperplasia: a Case Report

Primary unilateral macronodular adrenal hyperplasia with concomitant glucocorticoid and androgen excess and KDM1A inactivation

Genotype-phenotype landscape of pituitary adrenocorticotroph hormone adenoma